# RCT on Adjuvant TACE After Hepatectomy for HCC

> **NCT01512407** · NA · COMPLETED · sponsor: **Chinese University of Hong Kong** · enrollment: 58 (actual)

## Conditions studied

- Hepatocellular Carcinoma

## Interventions

- **PROCEDURE:** Transarterial chemoembolisation using cisplatin-lipiodol mixture

## Key facts

- **NCT ID:** NCT01512407
- **Lead sponsor:** Chinese University of Hong Kong
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-11
- **Primary completion:** 2019-05
- **Final completion:** 2019-12
- **Target enrollment:** 58 (ACTUAL)
- **Last updated:** 2022-03-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01512407

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01512407, "RCT on Adjuvant TACE After Hepatectomy for HCC". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01512407. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*